A Drosophilia Model of Amyotrophic Lateral Sclerosis
肌萎缩侧索硬化症的果蝇模型
基本信息
- 批准号:6669600
- 负责人:
- 金额:$ 17.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-01 至 2005-06-30
- 项目状态:已结题
- 来源:
- 关键词:Drosophilidae amyotrophic lateral sclerosis autosomal recessive trait behavior test biological signal transduction cytoskeleton degenerative motor system disease disease /disorder onset double stranded RNA electrophysiology gene expression gene interaction gene mutation gene targeting histopathology immunocytochemistry intracellular transport laboratory rabbit motor neurons neurogenetics neuromuscular system peptides phenotype technology /technique development
项目摘要
DESCRIPTION (provided by applicant): Amyotrophic lateral sclerosis 2 (ALS2) is an autosomal recessive form of juvenile onset ALS characterized by spasticity of limb and facial muscles resulting from degeneration of motor neurons in the central nervous system. A gene responsible for ALS2 disease has recently been cloned that encodes a protein (termed alsin) with domains suggestive of functions in cell signaling, intracellular trafficking, and cytoskeletal organization. To gain further insight into the normal biological function of this gene, we propose to create a model of this disorder in the fruit fly Drosophila melanogaster. The Drosophila ALS2 gene (DALS2) encodes a polypeptide with 23% amino acid identity (38% similarity) to the human alsin polypeptide and is broadly expressed in a variety of tissue types throughout development. We propose to generate mutations in DALS2 using gene-targeting and double stranded RNA interference methods. Resulting DALS2 mutants will be characterized for signs of progressive motor neuron dysfunction and defects in cell signaling, intracellular trafficking, and cytoskeletal assembly. Additionally, we will conduct screens for genetic modifiers of the DALS2 phenotypes to elucidate the biochemical pathways leading to neuronal dysfunction and death in this Drosophila ALS2 disease model. Results from this work should clarify the normal cellular role of the ALS2 gene and may reveal strategies for treatment of ALS disease.
描述(由申请人提供):肌萎缩侧索硬化2型(ALS 2)是一种常染色体隐性形式的青少年型ALS,其特征是中枢神经系统运动神经元变性导致的肢体和面部肌肉痉挛。最近已克隆了一个负责ALS2疾病的基因,该基因编码一种蛋白质(称为alsin),该蛋白质具有提示细胞信号传导、细胞内运输和细胞骨架组织功能的结构域。为了进一步了解该基因的正常生物学功能,我们建议在果蝇中建立这种疾病的模型。果蝇ALS2基因(DALS2)编码一种多肽,与人alsin多肽具有23%的氨基酸同一性(38%的相似性),并在整个发育过程中广泛表达于各种组织类型。我们建议使用基因靶向和双链RNA干扰方法在DALS2中产生突变。所得DALS2突变体将表征进行性运动神经元功能障碍的迹象和细胞信号传导、细胞内运输和细胞骨架组装的缺陷。此外,我们将进行DALS2表型的遗传修饰剂的筛选,以阐明导致果蝇ALS2疾病模型中神经元功能障碍和死亡的生化途径。这项工作的结果应该澄清ALS2基因的正常细胞作用,并可能揭示ALS疾病的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN M JACKSON其他文献
STEPHEN M JACKSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN M JACKSON', 18)}}的其他基金
B CELLS BEARING IGVH4-34+ BCRS: TARGET-SPECIFIC INFLUENCES ON B CELL ACTIVATION
携带 IGVH4-34 BCRS 的 B 细胞:对 B 细胞激活的靶标特异性影响
- 批准号:
7959383 - 财政年份:2009
- 资助金额:
$ 17.85万 - 项目类别:
B CELLS BEARING IGVH4-34+ BCRS: TARGET-SPECIFIC INFLUENCES ON B CELL ACTIVATION
携带 IGVH4-34 BCRS 的 B 细胞:对 B 细胞激活的靶标特异性影响
- 批准号:
7720058 - 财政年份:2008
- 资助金额:
$ 17.85万 - 项目类别:
B CELLS BEARING IGVH4-34+ BCRS: TARGET-SPECIFIC INFLUENCES ON B CELL ACTIVATION
携带 IGVH4-34 BCRS 的 B 细胞:对 B 细胞激活的靶标特异性影响
- 批准号:
7609779 - 财政年份:2007
- 资助金额:
$ 17.85万 - 项目类别:
B CELLS BEARING IGVH4-34+ BCRS: TARGET-SPECIFIC INFLUENCES ON B CELL ACTIVATION
携带 IGVH4-34 BCRS 的 B 细胞:对 B 细胞激活的靶标特异性影响
- 批准号:
7381149 - 财政年份:2006
- 资助金额:
$ 17.85万 - 项目类别:
A Drosophilia Model of Amyotrophic Lateral Schlerosis
肌萎缩侧索硬化症的果蝇模型
- 批准号:
6760848 - 财政年份:2003
- 资助金额:
$ 17.85万 - 项目类别:
SOMA-TO-GERMLINE SIGNALING IN OOGENESIS IN DROSOPHILA
果蝇卵发生过程中的体细胞到种系信号传导
- 批准号:
2884105 - 财政年份:1999
- 资助金额:
$ 17.85万 - 项目类别:
SOMA-TO-GERMLINE SIGNALING IN OOGENESIS IN DROSOPHILA
果蝇卵发生过程中的体细胞到种系信号传导
- 批准号:
6380133 - 财政年份:1999
- 资助金额:
$ 17.85万 - 项目类别:
SOMA-TO-GERMLINE SIGNALING IN OOGENESIS IN DROSOPHILA
果蝇卵发生过程中的体细胞到种系信号传导
- 批准号:
6176976 - 财政年份:1999
- 资助金额:
$ 17.85万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 17.85万 - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 17.85万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 17.85万 - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 17.85万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 17.85万 - 项目类别:
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 17.85万 - 项目类别:
Fellowship
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 17.85万 - 项目类别:
Operating Grants














{{item.name}}会员




